The potential of the nicotinic channel blocker tc-5214 as augmentation treatment in patients with major depression

Authors
Category Primary study
JournalEuropean Neuropsychopharmacology
Year 2010
This article has no abstract
Epistemonikos ID: fe0a2ad044f55494a7ad2f54c8ea360992bec1a7
First added on: Mar 01, 2025